Door to Needle Time: Gold Standard of Stroke Treatment Fatima Milfred, MD. Virginia Mason Medical Center March 16, 2018

Similar documents
ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Acute Stroke Care: the Nuts and Bolts of it. ECASS I and II ATLANTIS. Chris V. Fanale, MD Colorado Neurological Institute Swedish Medical Center

Emergency Department Management of Acute Ischemic Stroke

How to Interpret CT/CTA for Acute Stroke in the Age of Endovascular Clot Retrieval

Code Stroke Optimizing Stroke Care in the Field: The Alberta Experience

2018 Early Management of Acute Ischemic Stroke Guidelines Update

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

KPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke

Advancing Stroke Systems of Care to Improve Outcomes Update on Target: Stroke Phase II

Acute Stroke Protocols Modified- What s New in 2013

Acute brain vessel thrombectomie: when? Why? How?

Maximising Delivery of Thrombectomy

Endovascular Treatment for Acute Ischemic Stroke

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center

The DAWN of a New Era for Wake-up Stroke

Acute Stroke Treatment: Current Trends 2010

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

Endovascular Treatment Updates in Stroke Care

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

Acute Ischemic Stroke Imaging. Ronald L. Wolf, MD, PhD Associate Professor of Radiology

Case 1 5/26/2017 ENDOVASCULAR MECHANICAL THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE

Disclosure. Advances in Interventional Neurology. Disclosure. Natural History of Disease 3/15/2018. Vishal B. Jani MD

The tpa Cage Match. Disclosures. Cage Match. Cage Match 1/27/2014. January 8, Advisory Boards

Antithrombotics: Percent of patients with an ischemic stroke or TIA prescribed antithrombotic therapy at discharge. Corresponding

Comparison of Five Major Recent Endovascular Treatment Trials

Interventional Stroke Treatment

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

Practical Considerations in the Early Treatment of Acute Stroke

Stroke Clinical Trials Update Transitioning to an Anatomic Diagnosis in Ischemic Stroke

Endovascular Treatment of Ischemic Stroke

First Year of 24/7 ASU and Stroke Thrombolytic Service

Illinois Stroke System Policy Overview

Imaging Stroke: Is There a Stroke Equivalent of the ECG? Albert J. Yoo, MD Director of Acute Stroke Intervention Massachusetts General Hospital

Rural emergency department best practice for treatment of acute ischemic stroke

When Not To Give TPA Steve Phillips Division of Neurology

STAR- - Stroke Treatment Alliance of Rochester

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Stroke Belt Consortium

Role of recombinant tissue plasminogen activator in the updated stroke approach

Updates in Stroke Management. Jessica A Starr, PharmD, FCCP, BCPS Associate Clinical Professor Auburn University Harrison School of Pharmacy

Best medical therapy (includes iv t-pa in eligible patients)

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial

ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine

Mechanical thrombectomy in Plymouth. Will Adams. Will Adams

Parameter Optimized Treatment for Acute Ischemic Stroke

Managing the Measures: A Serious Look at Key Abstraction Concepts for the Comprehensive Stroke (CSTK) Measure Set Session 2

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

ACUTE STROKE IMAGING

Journal Club. 1. Develop a PICO (Population, Intervention, Comparison, Outcome) question for this study

Intravenous thrombolysis State of Art. Carlos A. Molina Stroke Unit. Hospital Vall d Hebron Barcelona

BY: Ramon Medina EMT-LP/RN

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Disclosures. Outline. Updated Recommendations for Using Alteplase (TPA) in Acute Ischemic Stroke

Emergency Room Procedure The first few hours in hospital...

Disclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

BY MARILYN M. RYMER, MD

Acute Stroke Management Conference 2019: Stroke Clinical Vignettes

ACUTE ISCHEMIC STROKE

Periinterventional management in acute neurointervention

Sinus Venous Thrombosis

Mechanical Thrombectomy: Where Are We Now? T. Adam Oliver, MD Tallahassee Neurological Clinic Tallahassee, Florida TMH Neurosymposium June 11, 2016

The Importance of Stroke Programs in an Acute Care Setting by Debbie Estes, RN, BSN Stroke Program Coordinator, Medical City of Dallas

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

Endovascular Stroke Therapy

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Jointly provided by Potomac Center for Medical Education and Rockpointe Supported by an educational grant from Genentech, A Member of the Roche Group

Lessons Learned from IMS III: Implications for the Future

Mechanical thrombectomy beyond the 6 hours. Mahmoud Rayes, MD Medical Director, Stroke program Greenville Memorial Hospital

framework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow

ENDOVASCULAR THERAPIES FOR ACUTE STROKE

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Acute Stroke Treatment: Mechanical Thrombectomy

Thrombolytics and Beyond

The Effect of Statin Therapy on Risk of Intracranial Hemorrhage

Acute Stroke Identification and Treatment

Advances in Neuro-Endovascular Care for Acute Stroke

Building a Stroke Portfolio. June 28, 2018

Figures for Draft Response to IMS III, MR RESCUE, and SYNTHSESIS Trials

Emergency Treatment of Ischemic Stroke

WHAT IS A STROKE? What causes a stroke? What disabilities can result from a stroke?

Historical. Medical Policy

Code Stroke Intervention: Endovascular Therapies for Stroke J. DIEGO LOZANO MD INTERVENTIONAL NEURORADIOLOGY

Broadening the Stroke Window in Light of the DAWN Trial

WAKE-UP has received funding from the European Union Seventh Framework Programme (FP7/ ) under grant agreement n

Stroke Systems of Care Claire Corbett, MMS, NRP Manager of Neurodiagnostics and Stroke Center New Hanover Regional Medical Center. What do we know?

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Strokecenter Key lessons of MR CLEAN study

Stroke Cart Improves Efficiency in Acute Ischemic Stroke Intervention

Stroke: The First Critical Hour. Alina Candal, RN, PCC, MICN Kevin Andruss, MD, FACEP

Acute Stroke Management What is State of the Art?

New Frontiers in Intracerebral Hemorrhage

Updated tpa Guidelines: Expanding the opportunity for good outcomes. Benjamin Morrow, MSN RN UPMC Stroke Institute

WHY TIMELINESS MATTERS. W&M Wren Association Lecture Series

Acute Stroke Treatment Update for 2008

Update on Thrombolysis and Thrombectomy. Seniorprofessur Neurologie UniversitätsKlinikum und Universität Heidelberg

William Barr, M.D. January 28, 2017

PHANTOM-S study Prehospital acute neurologic therapy and optimization of medical care in stroke Matthias Wendt on behalf of the PHANTOM-S study group

Transcription:

Door to Needle Time: Gold Standard of Stroke Treatment Fatima Milfred, MD Virginia Mason Medical Center March 16, 2018

2016 Virginia Mason Medical Center

No disclosure 2016 Virginia Mason Medical Center 3

Objectives General concepts about IV tpa Target: Stroke initiative Importance of door to needle time Role of tpa in patient outcome and Data First 24 h post IV tpa administration 2016 Virginia Mason Medical Center 4

5

6

7

Question for the audience How many neurons/synapses are lost per minute in a large vessel AIS? 1. 1.6 million/15 billion 2. 1.7 million/13 billion 3. 1.8 million/16 billion 4. 1.9 million/14 billion 2016 Virginia Mason Medical Center 8

Overview Benefits of IV tpa Timing for tpa National guidelines recommendations Are patients treated according to guidelines? 2016 Virginia Mason Medical Center 9

History National Institute of neurological disorder (NINDS) 1997 The Brain Attack Coalition s target 2000 Standard treatment with alteplase to reverse stroke (STARS) 2016 Virginia Mason Medical Center 10

How long can we go?

12

The European Study from Helsinki 2016 Virginia Mason Medical Center 13

14

15

16

17

Target Stroke Initiative

About Target: Stroke http://www.strokeassociation.org/strokeorg /Professionals/TargetStroke/About-Target- Stroke_UCM_432409_Article.jsp#.WpXmsK3ru so 2016 Virginia Mason Medical Center 19

20

21

22

23

What was the message from this study? Clear data supporting benefits of timely IV TPA in AIS. Time to treatment with IV TPA important determinant 90 day and 1 year functional outcome. Pooled analysis 6 randomized placebo controlled trials of IV tpa started within 360 minutes of sxs onset of stroke in 2775 pts: Odds of favorable 3 months outcome increased as on sent of treatment decreased Odds: 2. 8 for 0 to 90 min; 1. 6 for 91 to 180 min; 1.4 for 181 270 min and 1.2 for 271 360 min. Disparity: age, gender, sex Symptom onset to arrival times where shorter in patients with door to needle times > 60 min. 2016 Virginia Mason Medical Center 24

Quality Assessment of Practices 2016 Virginia Mason Medical Center 25

26

Research

28

Research investigation: DTN for tpa administration and clinical outcome Benefits of IV TPA are time-dependent Guidelines recommend a door to needle time of 60 minutes are less Studies have found that less than 30% of US patients are treated within this time window. 2016 Virginia Mason Medical Center 29

30

31

32

DTN times 2016 Virginia Mason Medical Center 33

Clinical outcomes 2016 Virginia Mason Medical Center 34

Various hospitals experiences Dr. Stroke Activation system Other Stroke centers experience 2016 Virginia Mason Medical Center 35

Various hospitals experiences 2016 Virginia Mason Medical Center 36

Various hospitals experiences 2016 Virginia Mason Medical Center 37

First 24 post IV tpa

39

First 24 h post IV tpa Rates of symptomatic intracerebral hemorrhage (sich) have varied (between 1.9% and 6.4%) Most cases of sich are caused by reperfusion injury. Population at risk: elderly, diabetes, severe hyperglycemia, uncontrolled HTN and larger hypodensity on baseline CT scan. Pts with microbleeds although this association is not entirely certain. Orolingual angioedema is a rare but potentially serious complication of rtpa administration. The risk is higher in patients previously taking angiotensin converting enzyme inhibitors. It is typically asymmetric and tends to involve the hemiparetic side. 2016 Virginia Mason Medical Center 40

41

Conclusion IV thrombolysis is the standard of care for eligible patients with acute ischemic stroke. Limitations: short time window (3 and 4.5 h), contraindication in patients with increased bleeding risk, IV rtpa often fails to recanalize proximal artery occlusions caused by large clots. Studies have found that less than 30% of US pts are treated within door to needle time of 60 minutes or less. Target: Stroke a multidimentional initiative elevates clinical performance in the care of acute ischemic stroke patient, facilitate a rapid integration of evidence into clinical practice and improve outcomes. Implementation of a national quality improvement initiative was associated with improved timelines of TPA administration following acute ischemic stroke, which correlates with lower in-hospital mortality and intracranial hemorrhage along with an increase percentage of patients discharged home. Close observation, frequent neurochecks/blood pressure/monitoring signs and symptoms of ICH as well as adverse drug reaction are crucial in the first 24 hours after IV tpa administration for patient safety. 2016 Virginia Mason Medical Center 42